These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12901507)

  • 1. Effects of alendronate on structural properties of trabecular bone in dogs.
    Jianhua H; Liang Z; Lilian Z; Gongyi H
    Chin Med Sci J; 2002 Dec; 17(4):210-4. PubMed ID: 12901507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone.
    Hu JH; Ding M; Søballe K; Bechtold JE; Danielsen CC; Day JS; Hvid I
    Bone; 2002 Nov; 31(5):591-7. PubMed ID: 12477573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women.
    Recker R; Masarachia P; Santora A; Howard T; Chavassieux P; Arlot M; Rodan G; Wehren L; Kimmel D
    Curr Med Res Opin; 2005 Feb; 21(2):185-94. PubMed ID: 15801989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
    Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
    J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.
    Campbell GM; Bernhardt R; Scharnweber D; Boyd SK
    Bone; 2011 Aug; 49(2):225-32. PubMed ID: 21515436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.
    Ding M; Day JS; Burr DB; Mashiba T; Hirano T; Weinans H; Sumner DR; Hvid I
    Calcif Tissue Int; 2003 Jun; 72(6):737-44. PubMed ID: 14563003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model.
    Thomopoulos S; Matsuzaki H; Zaegel M; Gelberman RH; Silva MJ
    J Orthop Res; 2007 Apr; 25(4):473-9. PubMed ID: 17205555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical evaluation of bone samples following alendronate therapy in healthy male dogs.
    Fischer KJ; Vikoren TH; Ney S; Kovach C; Hasselman C; Agrawal M; Rubash H; Shanbhag AS
    J Biomed Mater Res B Appl Biomater; 2006 Jan; 76(1):143-8. PubMed ID: 16047323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin K(1) on fluoride-induced bone changes in growing rats: a histomorphometric and radiodensitometric study.
    Cadir B; Kürkcü M; Oz IA; Benlidayi ME
    Arch Oral Biol; 2005 Oct; 50(10):889-95. PubMed ID: 16137498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
    Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
    J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse.
    Misof BM; Roschger P; Baldini T; Raggio CL; Zraick V; Root L; Boskey AL; Klaushofer K; Fratzl P; Camacho NP
    Bone; 2005 Jan; 36(1):150-8. PubMed ID: 15664013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
    J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
    Shomali T; Rezaian M; Rassouli A; Asadi F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):46-50. PubMed ID: 19302435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats.
    Noa M; Más R; Mendoza S; Gámez R; Mendoza N
    Drugs Exp Clin Res; 2004; 30(1):35-41. PubMed ID: 15134389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
    Cho DC; Kim KT; Jeon Y; Sung JK
    Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.